Less than a week after FDA opened the faucet for digital health products treating psychiatric conditions during the COVID-19 health crisis, Akili has fast-tracked and released its approval-pending digital therapeutic for children with ADHD.
Now known as Endeavor and flanked by a symptom tracker and caretaker support line, the video game-like app will be provided at no cost for a limited time to...
From syringes to workflow management systems, healthcare is no stranger to adopting new technologies into standard care. As digital and connected technologies continue to stake their claim in the industry, the last few years have seen the rise of a new type of health technology product — one that promises measurable health outcomes validated by traditional clinical trials.
“You had a little...
There’s plenty of debate about the impact of consumer-level computer or video games on children’s brains. But a new study from the University of California, San Francisco published in PLOS One shows that, in a clinical setting, games that have been developed to function as a medical device may be beneficial to children with certain cognitive impairments.
UCSF and Akili Interactive Labs, which is...
Boston-based Akili Interactive Labs and Pfizer have released data from a collaborative study showing the use of Akili’s digital, cognitive measurement platform can detect biomarkers of Alzheimer’s disease.
The study, which began in 2014, used Akili’s screening technology called AD Screen. The program targets the brain's interference processing system and then uses an algorithm to deploy a...
Project: EVO, an iOS-based video game intervention developed by Akili Interactive Labs, may be an effective method for improving attention and memory in children with ADHD, according to a poster presented at the American Academy of Child and Adolescent Psychiatry’s 62nd annual meeting today.
Researchers from Florida Clinical Research Center, SUNY Upstate Medical University, and Duke University...
Boston-based Akili Interactive Labs has partnered with Delivering Scientific Innovation for Autism (DELSIA), a not-for-profit subsidiary of Autism Speaks. DELSIA is funding an efficacy study of Akili's iOS-based game, called Project: EVO, with children that have high-functioning autism and ADHD.
The trial will be a blind, randomized, placebo-controlled study "that will look to measure cognitive...
Boston-based Akili Interactive Labs partnered with Pfizer to conduct a study of Akili's iOS-based game, Project Evo, in the hopes of using the game to detect indications of Alzheimer's in healthy individuals.
The month-long study of 100 participants includes a mix of some who have risk markers of potentially developing Alzheimer's and some who do not. All participants will take the game home and...
A study participant playing Neuroracer.
A new study from the University of California, San Francisco shows that a specially designed mobile video game could improve neural plasticity in older adults, improving their ability to multitask and to filter out distractions. A spin-off company is currently testing a version of the game for the possible treatment of ADHD, depression, or autism...
